loading...| Preferred Name |
exenatide |
|
| Synonyms |
Byetta |
|
| Definitions |
A 39 amino acid peptide and synthetic version of exendin-4, a hormone found in the saliva of the venomous lizard Gila monster, with insulin secretagogue and antihyperglycemic activity. Exenatide is administered subcutaneously and mimics human glucagon-like peptide-1 (GLP-1). Compared to GLP-1, exenatide has a longer half-life of 2.4 hours. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C65611" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C65611" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000719492 |
|
| altLabel |
Byetta |
|
| CAS Registry |
141732-76-5 |
|
| cui |
C1636686 C0167117 |
|
| DATE FIRST PUBLISHED |
2011-12-08 |
|
| Date last modified |
2011-12-08 |
|
| definition |
A 39 amino acid peptide and synthetic version of exendin-4, a hormone found in the saliva of the venomous lizard Gila monster, with insulin secretagogue and antihyperglycemic activity. Exenatide is administered subcutaneously and mimics human glucagon-like peptide-1 (GLP-1). Compared to GLP-1, exenatide has a longer half-life of 2.4 hours. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C65611" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C65611" NCI Thesaurus) |
|
| LT |
TRD |
|
| NCI ID |
C65611 |
|
| notation |
CDR0000719492 |
|
| ORIG STY |
Drug/agent |
|
| prefLabel |
exenatide |
|
| tui |
T116 T121 |